We are live on ! Find out more
VCYT icon

Veracyte

74 hedge funds and large institutions have $160M invested in Veracyte in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 3

191% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 11

174% more call options, than puts

Call options by funds: $2.9M | Put options by funds: $1.06M

62.83% more ownership

Funds ownership: 0%62.83% (+63%)

35% more capital invested

Capital invested by funds: $118M → $160M (+$41.4M)

35% more funds holding

Funds holding: 5574 (+19)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
74
Holders Change
+19
Holders Change %
+34.55%
% of All Funds
1.85%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
32
Reduced
11
Closed
3
Calls
$2.9M
Puts
$1.06M
Net Calls
+$1.84M
Net Calls Change
+$2.37M
Name Holding Trade Value Shares
Change
Change in
Stake
RA
76
Royce & Associates
New York
-$205K -27,000 Closed
Barclays
77
Barclays
United Kingdom
-$1K -119 Closed

VCYT Hedge Fund Activity: Q4 2016 in Review

74 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2016, worth a combined $160M — up 35% from $118M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new VCYT positions and 3 closed out — a net gain of 19 holders — while 32 added to existing stakes and 11 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $13.4M. The largest seller was General Electric, exiting entirely with an estimated $2.01M sold.

  • 74 institutional investors held Veracyte (VCYT) as of Q4 2016, up from 55 in Q3 2016.
  • Funds reported $160M of Veracyte stock for Q4 2016, up 35% quarter-over-quarter.
  • 22 funds opened new Veracyte positions in Q4 2016 and 3 closed out, a net change of +19 holders.
  • The largest Veracyte buyer in Q4 2016 was Broadfin Capital, an estimated $13.4M added.
  • The largest Veracyte seller in Q4 2016 was General Electric, an estimated $2.01M sold.

Based on aggregated 13F filings for Q4 2016.